Peptide Inhibitors

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
CAT# Product Name M.W Molecular Formula Inquiry
R2135 N-Fmoc-N-(2,2,2-trifluoroethyl)glycine 379.3 C19H16F3NO4
R2136 N-Fmoc-4-methyl-L-tryptophan 440.5 C27H24N2O4
R2137 Propargylglycine, DL- 113.11 C5H7NO2
R2138 N-Fmoc-4-methoxy-L-tryptophan 456.5 C27H24N2O5
R2139 N-Fmoc-(S)-2-aminoheptanoic acid 367.4 C22H25NO4
R2140 N-Fmoc-3-methyl-L-tyrosine 417.5 C25H23NO5
R2141 n-Fmoc-5,5-dimethyl-l-norleucine 381.5 C23H27NO4
R2142 N-Fmoc-N-(3-pyridinylmethyl)-glycine 388.4 C23H20N2O4
R2143 N-Fmoc-N-(cyclohexylmethyl)-glycine 393.5 C24H27NO4
R2144 N-Fmoc-O-methyl-3-chloro-L-tyrosine 451.9 C25H22ClNO5
R2145 N-alpha-Fmoc-S-2,4,6-trimethoxyphenylthio-L-cysteine 541.6 C27H27NO7S2
R2146 N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N6-(1-(2-hydroxy-4,4-dimethyl-6-oxocyclohex-1-en-1-yl)ethylidene)-N2-methyl-L-lysine 546.7 C32H38N2O6
R2147 N-Fmoc-4-methylbenzyl-glycine 401.5 C25H23NO4
R2148 Boc-Val-Cit-OH 374.43 C16H30N4O6
R2149 N-Fmoc-2-methylbenzyl-glycine 401.5 C25H23NO4
R2150 N-Fmoc-4-chloro-D-homophenylalanine 435.9 C25H22ClNO4
R2151 N-Fmoc-(S)-3-(methylamino)butanoic acid 339.4 C20H21NO4
R2152 N-Fmoc-N-(2-fluorobenzyl)-glycine 405.4 C24H20FNO4
R2153 N-Fmoc-3-fluoro-L-tyrosine 421.4 C24H20FNO5
R2154 N-Fmoc-O-(4-fluorophenyl)-L-serine 421.4 C24H20FNO5